Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfacalcidiol for Left Ventricular Hypertrophy in Chronic Kidney Disease
NCT00175149Phase 4Terminated
- Start
- Jan 2002
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfacalcidol in left ventricular hypertrophy (LVH), secondary hyperparathyroidism (SHPT). Started Jan 2002; status: terminated.
02
Drugs
alfacalcidol
03
Conditions
left ventricular hypertrophy (LVH)secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00175149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175149.